Asthma Therapeutics Market Forecast 2026–2035: Data Trends and Industry Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the asthma therapeutics market from 2026–2035 with trusted insights from The Business Research Company

How much is the Asthma Therapeutics Market valued at in 2026, and what valuation is forecast for 2030?

The asthma therapeutics market size has seen significant expansion in recent years. This market is forecast to increase from $33.11 billion in 2025 to $35.73 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.9%. The growth observed in the past can be attributed to several factors, including the restricted access to biologics, a dependence on short-acting beta agonists, the increasing global incidence of asthma, a rise in visits to hospitals and specialty clinics, and the widespread adoption of oral and inhaled medications.

The asthma therapeutics market is projected to experience substantial expansion in the coming years, with its size forecast to reach $47.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.6%. This anticipated growth during the forecast period is attributable to factors such as the development of innovative biologics and combination therapies, the broader adoption of telemedicine and digital health monitoring, heightened awareness of preventive treatments, improved healthcare accessibility in developing markets, and increased investment in research and drug development. Key trends anticipated over the forecast timeframe encompass the increasing integration of personalized asthma therapies, a surge in the utilization of inhalers and biologics, the proliferation of homecare and remote monitoring solutions, an escalating preference for combination inhalers, and a strengthened emphasis on asthma care for both pediatric and geriatric populations.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25702&type=smp

What Drivers Are Influencing The Growth Of The Asthma Therapeutics Market?

The escalating incidence of asthma is projected to fuel the expansion of the asthma therapeutics market in the future. Asthma is defined as a chronic condition characterized by inflammation and swelling within the airways, which leads to their constriction, thereby impeding air passage from the nose and mouth to the lungs. This rise in asthma prevalence stems from a growing presence of pollutants, known to irritate airways and elevate the likelihood of developing the disorder. Asthma therapeutics play a crucial role in managing the condition by regulating inflammation in the airways, alleviating symptoms, and averting asthma attacks. For illustration, data from May 2025, released by the UK Parliament, a government entity in the UK, revealed that 3,886,879 individuals aged six and above were diagnosed with asthma in 2023-24, representing 6.5% of England’s total population. Consequently, the heightened occurrence of asthma is a key factor propelling the expansion of the asthma therapeutics market.

How Is The Asthma Therapeutics Market Organized Into Various Segments?

The asthma therapeutics market covered in this report is segmented –

1) By Drug Class: Inhaled Corticosteroids (ICS), Long-Acting Beta Agonists (LABA), Leukotriene Receptor Antagonists (LTRA), Short-Acting Beta Agonists (SABA), Biologics, Combination Inhalers (ICS + LABA)

2) By Treatment Stage: Acute Treatment, Long-Term Control, Preventive Treatment, Maintenance Regimens, Rescue Medications

3) By Route Of administration: Oral, Inhaled, Intravenous, Subcutaneous

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End-User: Hospitals, Homecare, Specialty Clinics

Subsegments:

1) By Inhaled Corticosteroids (ICS): Fluticasone, Budesonide, Beclomethasone, Mometasone, Ciclesonide

2) By Long-Acting Beta Agonists (LABA): Salmeterol, Formoterol, Indacaterol, Olodaterol

3) By Leukotriene Receptor Antagonists (LTRA): Montelukast, Zafirlukast, Pranlukast

4) By Short-Acting Beta Agonists (SABA): Albuterol (Salbutamol), Levalbuterol, Terbutaline

5) By Biologics: Omalizumab, Mepolizumab, Benralizumab, Dupilumab, Reslizumab

6) By Combination Inhalers (ICS + LABA): Fluticasone + Salmeterol, Budesonide + Formoterol, Mometasone + Indacaterol, Beclomethasone + Formoterol

What Trends Are Reshaping The Dynamics Of The Asthma Therapeutics Market?

Companies operating within the asthma therapeutics market are directing their efforts towards the creation of innovative solutions, such as the anti-inflammatory rescue inhaler, aiming to improve symptom alleviation, inflammation regulation, and general disease management. The anti-inflammatory rescue inhaler functions as a dual-action therapeutic method, integrating a quick-acting bronchodilator with an inhaled corticosteroid within a single inhaler, thereby facilitating capabilities such as swift bronchodilation, immediate inflammation reduction, and the avoidance of severe asthma episodes. For example, in January 2024, AstraZeneca plc, a UK-based biopharmaceutical company, launched AIRSUPRA, an FDA-approved anti-inflammatory rescue inhaler engineered to deliver instant symptom relief alongside rapid anti-inflammatory action, offering as-needed dual-mechanism dosing, real-time suppression of airway inflammation, and support in preventing lung-function decline associated with exacerbations. AIRSUPRA contributes to better asthma control, decreases the likelihood of severe attacks, and strengthens the overall efficacy of rescue therapy.

Who Are The Core Companies Influencing Trends In The Asthma Therapeutics Market?

Major companies operating in the asthma therapeutics market are Roche Holding AG, Merck & Co Inc., Pfizer Inc., AstraZeneca plc, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, Mylan N.V.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/asthma-therapeutics-global-market-report

Which Regions Are Projected To Dominate The Asthma Therapeutics Market In The Coming Years?

North America was the largest region in the asthma therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Asthma Therapeutics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25702&type=smp

Browse Through More Reports Similar to the Global Asthma Therapeutics Market 2026, By The Business Research Company

Asthma Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795